Ashish Chogle
Pediatric Gastroenterology · Orange, CANPI 1023273141
Payments from drug & device makers
What this record shows
The money is spread across several categories — food and beverage (54.4%), consulting fees and education — rather than concentrated in one kind of arrangement. 18 manufacturers reported payments, led by Neuraxis, Inc. at 48.3% of the total. Reporting peaked in 2020 at $1,061 and has fallen 76.5% since, to $249 in 2025.
Across 76 payments — averaging $31.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Neuraxis, Inc.$1K
- Mirum Pharmaceuticals, Inc.$215
- AbbVie$178
- Travere Therapeutics, Inc.$129
- Sanofi$125
- Fresenius Kabi USA, LLC$122
- plus $470 from 12 others
Across 21 payments — averaging $5660.62 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Neuraxis, Inc.$99K
- QOL Medical, LLC$12K
- Takeda Pharmaceuticals U.S.A., Inc.$8K
What the payments were for
- Consulting fees$1,00042%
- Food & beverage$1,30354%
- Education$914%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Neuraxis, Inc. | 2 | $1,155 |
| Mirum Pharmaceuticals, Inc. | 4 | $215 |
| AbbVie | 4 | $178 |
| Travere Therapeutics, Inc. | 45 | $129 |
| Sanofi | 1 | $125 |
| Fresenius Kabi USA, LLC | 1 | $122 |
| QOL Medical, LLC | 3 | $91 |
| Ironwood Pharmaceuticals, Inc | 2 | $84 |
| Nestle Healthcare Nutrition Inc. | 4 | $73 |
| Alcresta Therapeutics, Inc. | 2 | $44 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $31 |
| Albireo Pharma, Inc. | 1 | $26 |
| Kyowa Kirin, Inc. | 1 | $24 |
| Aquestive Therapeutics, Inc. | 1 | $22 |
| Tolmar, Inc. | 1 | $22 |
| Rhythm Pharmaceuticals, Inc. | 1 | $21 |
| Olympus America Inc. | 1 | $20 |
| Concordia Pharmaceuticals Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$2,393 in reported general payments places this provider in the 75th percentile of 220 pediatric gastroenterology providers in California.
See all pediatric gastroenterology providers in California →
Other pediatric gastroenterology in Orange
- Anup PatelOrange$7K
- Kenneth GrantOrange$4K
- Bassam YounesOrange$2K
- Gregory WongOrange$2K
- David ZiringLos Angeles$206K
- Nathan MinkoffMadera$131K
- Paul HarmatzOakland$109K
- Robert VenickLos Angeles$78K
- Jessica DeasLos Angeles$74K
- Amber HildrethSan Diego$67K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.